Task: Answer the multiple choice question.
Query: Which drug exhibits a 22.419\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COc1ccc2[nH]cc(C=O)c2c1
b. C[C@H](NC(=O)c1ccccc1Cl)C(=O)NCc1cccs1
c. Cc1cccc(CN2CCN(Cc3nc4c(s3)CCCC4)CC2CCO)n1
Answer: b. C[C@H](NC(=O)c1ccccc1Cl)C(=O)NCc1cccs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C[C@H](NC(=O)c1ccccc1Cl)C(=O)NCc1cccs1
C[C@H](NC(=O)c1ccccc1Cl)C(=O)NCc1cccs1
2-chloro-N-[(2S)-1-oxo-1-(thiophen-2-ylmethylamino)propan-2-yl]benzamide